Who are SynOx Therapeutics Ltd's investors?

SynOx Therapeutics Ltd's investors include HealthCap, Bioqube Ventures, Forbion, Gimv, Medicxi.

SynOx Therapeutics Ltd

Founded 2020 · 33 employees on LinkedIn · 5 known investors

Find your way into SynOx Therapeutics Ltd

SynOx Therapeutics develops emactuzumab, a monoclonal antibody treatment for tenosynovial giant cell tumours (TGCT) and macrophage-mediated diseases. The company focuses on bringing a differentiated drug candidate through clinical development and commercialisation to address unmet patient needs in rare and debilitating diseases.

Biotech Healthtech Medical Devices

Founders & leadership

Ray BarlowinChief Executive Officer

Investors · 5

HealthCap✓ verifiedStockholm

Bioqube Ventures✓ verifiedBrussels · $108K – $6.5M

Forbion✓ verifiedNaarden

Gimvreported · 2 sourcesAntwerp · $21M – $430M

Medicxireported · 2 sourcesLondon

Funding

SEC filings, press & company announcements

Undisclosed amountSeries ANov 2020
HealthCap (lead), Medicxi (lead), Forbion, Gimv
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

SynOx Therapeutics | EU-Startupseu-startups.com · Jun 2022

SynOx Therapeutics raises €37M in Series A Financingprnewswire.com · Nov 2020

SynOx Therapeutics secures €37M from HealthCap and Medicxi in co-lead, joined by Forbion and Gimv | Nordic 9nordic9.com

Frequently asked questions

What does SynOx Therapeutics Ltd do?: SynOx Therapeutics develops emactuzumab, a monoclonal antibody treatment for tenosynovial giant cell tumours (TGCT) and macrophage-mediated diseases. The company focuses on bringing a differentiated drug candidate through clinical development and commercialisation to address unmet patient needs in rare and debilitating diseases.
Who are SynOx Therapeutics Ltd's investors?: SynOx Therapeutics Ltd's investors include HealthCap, Bioqube Ventures, Forbion, Gimv, Medicxi.